Cite

HARVARD Citation

    Schain, F. et al. (2019). Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population‐based cohort study in Sweden and Norway. European journal of haematology. pp. 614-619. [Online]. 
  
Back to record